New generation estrogen receptor-targeted agents in breast cancer: present situation and future prospectives
Endocrine therapy that blocks estrogen receptor signaling has been effective for decades as a primary treatment choice for breast cancer patients expressing the estrogen receptor. However, the issue of drug resistance poses a significant clinical challenge. It is therefore critically important to cr...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Compuscript Ltd
2024-03-01
|
Series: | Acta Materia Medica |
Subjects: | |
Online Access: | https://www.scienceopen.com/hosted-document?doi=10.15212/AMM-2024-0006 |